M. Usala
Impact in
- Oncology top 1%
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer survivorship and care
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
M. Usala
39 papers receiving 6.9k citations
M. Usala's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 2.1k
- Otorhinolaryngology 257
- Cancer Research 700
- Pulmonary and Respiratory Medicine 1.2k
- Reproductive Medicine 266
Countries citing papers authored by M. Usala
This map shows the geographic impact of M. Usala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Usala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Usala more than expected).
Fields of papers citing papers by M. Usala
This network shows the impact of papers produced by M. Usala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Usala. The network helps show where M. Usala may publish in the future.
Co-authors
The 1 scholars most cited alongside M. Usala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Hit paper breakdown → | 2018 | 3985 |
| 2 | Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study Hit paper breakdown → | 2015 | 390 |
| 3 | Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study Hit paper breakdown → | 2017 | 380 |
| 4 | 2015 | 223 | |
| 5 | 2017 | 160 | |
| 6 | 2015 | 138 | |
| 7 | 2015 | 125 | |
| 8 | 2016 | 112 | |
| 9 | 2015 | 109 | |
| 10 | Italian cancer figures, report 2012: Cancer in children and adolescents. | 2013 | 106 |
| 11 | 2015 | 106 | |
| 12 | 2016 | 106 | |
| 13 | 2015 | 89 | |
| 14 | 2015 | 87 | |
| 15 | 2015 | 81 | |
| 16 | 2017 | 80 | |
| 17 | Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study Hit paper breakdown → | 2024 | 80 |
| 18 | 2015 | 72 | |
| 19 | 2018 | 69 | |
| 20 | 2015 | 68 |
About M. Usala
M. Usala is a scholar working on Genetics, Oncology, Epidemiology, Public Health, Environmental and Occupational Health and Reproductive Medicine, having authored 39 papers that have together received 7.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Occupational and environmental lung diseases (3 papers), Multiple and Secondary Primary Cancers (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Global Cancer Incidence and Screening (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Oncology (2.1k citations), Otorhinolaryngology (257 citations), Cancer Research (700 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Reproductive Medicine (266 citations). M. Usala has collaborated with scholars based in Italy, Spain and France. Frequent co-authors include Carlo Pavone. Their work appears in journals such as European Journal of Cancer, Neuro-Oncology, European Journal of Surgical Oncology, The Lancet Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.